The ART Advantage: Health Care Utilization for Diabetes and Hypertension in Rural South Africa.
Identifieur interne : 000772 ( PubMed/Corpus ); précédent : 000771; suivant : 000773The ART Advantage: Health Care Utilization for Diabetes and Hypertension in Rural South Africa.
Auteurs : Jennifer Manne-Goehler ; Livia Montana ; Francesc Xavier G Mez-Olivé ; Julia Rohr ; Guy Harling ; Ryan G. Wagner ; Alisha Wade ; Chodziwadziwa W. Kabudula ; Pascal Geldsetzer ; Kathleen Kahn ; Stephen Tollman ; Lisa F. Berkman ; Till W. B Rnighausen ; Thomas A. GazianoSource :
- Journal of acquired immune deficiency syndromes (1999) [ 1944-7884 ] ; 2017.
English descriptors
- KwdEn :
- Adult, Anti-HIV Agents (therapeutic use), Comorbidity, Diabetes Mellitus (epidemiology), Diabetes Mellitus (therapy), Female, HIV Infections (complications), HIV Infections (drug therapy), HIV Infections (epidemiology), Humans, Hypertension (epidemiology), Hypertension (therapy), Longitudinal Studies, Male, Middle Aged, Patient Acceptance of Health Care (statistics & numerical data), Population Surveillance, Prevalence, Program Evaluation, Rural Health Services (utilization), Rural Population, South Africa (epidemiology).
- MESH :
- chemical , therapeutic use : Anti-HIV Agents.
- complications : HIV Infections.
- drug therapy : HIV Infections.
- epidemiology : Diabetes Mellitus, HIV Infections, Hypertension, South Africa.
- statistics & numerical data : Patient Acceptance of Health Care.
- therapy : Diabetes Mellitus, Hypertension.
- utilization : Rural Health Services.
- Adult, Comorbidity, Female, Humans, Longitudinal Studies, Male, Middle Aged, Population Surveillance, Prevalence, Program Evaluation, Rural Population.
Abstract
The prevalence of diabetes and hypertension has increased in HIV-positive populations, but there is limited understanding of the role that antiretroviral therapy (ART) programs play in the delivery of services for these conditions. The aim of this study is to assess the relationship between ART use and utilization of health care services for diabetes and hypertension.
DOI: 10.1097/QAI.0000000000001445
PubMed: 28696346
Links to Exploration step
pubmed:28696346Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The ART Advantage: Health Care Utilization for Diabetes and Hypertension in Rural South Africa.</title><author><name sortKey="Manne Goehler, Jennifer" sort="Manne Goehler, Jennifer" uniqKey="Manne Goehler J" first="Jennifer" last="Manne-Goehler">Jennifer Manne-Goehler</name><affiliation><nlm:affiliation>*Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA;†Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA;‡Harvard Center for Population and Development Studies, Harvard University, Cambridge, MA;§Medical Research Council/Wits Rural Public Health and Health Transitions Research Unit, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa;‖Africa Health Research Institute (AHRI), KwaZulu-Natal, South Africa;¶Research Department of Infection and Population Health, University College London, London, United Kingdom;#INDEPTH Network, Accra, Ghana;**Institute of Public Health, University of Heidelberg, Heidelberg, Germany;††Department of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and‡‡Center for Health Decision Science, Harvard Medical School, Boston, MA.</nlm:affiliation></affiliation></author><author><name sortKey="Montana, Livia" sort="Montana, Livia" uniqKey="Montana L" first="Livia" last="Montana">Livia Montana</name></author><author><name sortKey="G Mez Olive, Francesc Xavier" sort="G Mez Olive, Francesc Xavier" uniqKey="G Mez Olive F" first="Francesc Xavier" last="G Mez-Olivé">Francesc Xavier G Mez-Olivé</name></author><author><name sortKey="Rohr, Julia" sort="Rohr, Julia" uniqKey="Rohr J" first="Julia" last="Rohr">Julia Rohr</name></author><author><name sortKey="Harling, Guy" sort="Harling, Guy" uniqKey="Harling G" first="Guy" last="Harling">Guy Harling</name></author><author><name sortKey="Wagner, Ryan G" sort="Wagner, Ryan G" uniqKey="Wagner R" first="Ryan G" last="Wagner">Ryan G. Wagner</name></author><author><name sortKey="Wade, Alisha" sort="Wade, Alisha" uniqKey="Wade A" first="Alisha" last="Wade">Alisha Wade</name></author><author><name sortKey="Kabudula, Chodziwadziwa W" sort="Kabudula, Chodziwadziwa W" uniqKey="Kabudula C" first="Chodziwadziwa W" last="Kabudula">Chodziwadziwa W. Kabudula</name></author><author><name sortKey="Geldsetzer, Pascal" sort="Geldsetzer, Pascal" uniqKey="Geldsetzer P" first="Pascal" last="Geldsetzer">Pascal Geldsetzer</name></author><author><name sortKey="Kahn, Kathleen" sort="Kahn, Kathleen" uniqKey="Kahn K" first="Kathleen" last="Kahn">Kathleen Kahn</name></author><author><name sortKey="Tollman, Stephen" sort="Tollman, Stephen" uniqKey="Tollman S" first="Stephen" last="Tollman">Stephen Tollman</name></author><author><name sortKey="Berkman, Lisa F" sort="Berkman, Lisa F" uniqKey="Berkman L" first="Lisa F" last="Berkman">Lisa F. Berkman</name></author><author><name sortKey="B Rnighausen, Till W" sort="B Rnighausen, Till W" uniqKey="B Rnighausen T" first="Till W" last="B Rnighausen">Till W. B Rnighausen</name></author><author><name sortKey="Gaziano, Thomas A" sort="Gaziano, Thomas A" uniqKey="Gaziano T" first="Thomas A" last="Gaziano">Thomas A. Gaziano</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28696346</idno><idno type="pmid">28696346</idno><idno type="doi">10.1097/QAI.0000000000001445</idno><idno type="wicri:Area/PubMed/Corpus">000772</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000772</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The ART Advantage: Health Care Utilization for Diabetes and Hypertension in Rural South Africa.</title><author><name sortKey="Manne Goehler, Jennifer" sort="Manne Goehler, Jennifer" uniqKey="Manne Goehler J" first="Jennifer" last="Manne-Goehler">Jennifer Manne-Goehler</name><affiliation><nlm:affiliation>*Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA;†Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA;‡Harvard Center for Population and Development Studies, Harvard University, Cambridge, MA;§Medical Research Council/Wits Rural Public Health and Health Transitions Research Unit, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa;‖Africa Health Research Institute (AHRI), KwaZulu-Natal, South Africa;¶Research Department of Infection and Population Health, University College London, London, United Kingdom;#INDEPTH Network, Accra, Ghana;**Institute of Public Health, University of Heidelberg, Heidelberg, Germany;††Department of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and‡‡Center for Health Decision Science, Harvard Medical School, Boston, MA.</nlm:affiliation></affiliation></author><author><name sortKey="Montana, Livia" sort="Montana, Livia" uniqKey="Montana L" first="Livia" last="Montana">Livia Montana</name></author><author><name sortKey="G Mez Olive, Francesc Xavier" sort="G Mez Olive, Francesc Xavier" uniqKey="G Mez Olive F" first="Francesc Xavier" last="G Mez-Olivé">Francesc Xavier G Mez-Olivé</name></author><author><name sortKey="Rohr, Julia" sort="Rohr, Julia" uniqKey="Rohr J" first="Julia" last="Rohr">Julia Rohr</name></author><author><name sortKey="Harling, Guy" sort="Harling, Guy" uniqKey="Harling G" first="Guy" last="Harling">Guy Harling</name></author><author><name sortKey="Wagner, Ryan G" sort="Wagner, Ryan G" uniqKey="Wagner R" first="Ryan G" last="Wagner">Ryan G. Wagner</name></author><author><name sortKey="Wade, Alisha" sort="Wade, Alisha" uniqKey="Wade A" first="Alisha" last="Wade">Alisha Wade</name></author><author><name sortKey="Kabudula, Chodziwadziwa W" sort="Kabudula, Chodziwadziwa W" uniqKey="Kabudula C" first="Chodziwadziwa W" last="Kabudula">Chodziwadziwa W. Kabudula</name></author><author><name sortKey="Geldsetzer, Pascal" sort="Geldsetzer, Pascal" uniqKey="Geldsetzer P" first="Pascal" last="Geldsetzer">Pascal Geldsetzer</name></author><author><name sortKey="Kahn, Kathleen" sort="Kahn, Kathleen" uniqKey="Kahn K" first="Kathleen" last="Kahn">Kathleen Kahn</name></author><author><name sortKey="Tollman, Stephen" sort="Tollman, Stephen" uniqKey="Tollman S" first="Stephen" last="Tollman">Stephen Tollman</name></author><author><name sortKey="Berkman, Lisa F" sort="Berkman, Lisa F" uniqKey="Berkman L" first="Lisa F" last="Berkman">Lisa F. Berkman</name></author><author><name sortKey="B Rnighausen, Till W" sort="B Rnighausen, Till W" uniqKey="B Rnighausen T" first="Till W" last="B Rnighausen">Till W. B Rnighausen</name></author><author><name sortKey="Gaziano, Thomas A" sort="Gaziano, Thomas A" uniqKey="Gaziano T" first="Thomas A" last="Gaziano">Thomas A. Gaziano</name></author></analytic><series><title level="j">Journal of acquired immune deficiency syndromes (1999)</title><idno type="eISSN">1944-7884</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Anti-HIV Agents (therapeutic use)</term><term>Comorbidity</term><term>Diabetes Mellitus (epidemiology)</term><term>Diabetes Mellitus (therapy)</term><term>Female</term><term>HIV Infections (complications)</term><term>HIV Infections (drug therapy)</term><term>HIV Infections (epidemiology)</term><term>Humans</term><term>Hypertension (epidemiology)</term><term>Hypertension (therapy)</term><term>Longitudinal Studies</term><term>Male</term><term>Middle Aged</term><term>Patient Acceptance of Health Care (statistics & numerical data)</term><term>Population Surveillance</term><term>Prevalence</term><term>Program Evaluation</term><term>Rural Health Services (utilization)</term><term>Rural Population</term><term>South Africa (epidemiology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-HIV Agents</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Diabetes Mellitus</term><term>HIV Infections</term><term>Hypertension</term><term>South Africa</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Patient Acceptance of Health Care</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Diabetes Mellitus</term><term>Hypertension</term></keywords><keywords scheme="MESH" qualifier="utilization" xml:lang="en"><term>Rural Health Services</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Comorbidity</term><term>Female</term><term>Humans</term><term>Longitudinal Studies</term><term>Male</term><term>Middle Aged</term><term>Population Surveillance</term><term>Prevalence</term><term>Program Evaluation</term><term>Rural Population</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The prevalence of diabetes and hypertension has increased in HIV-positive populations, but there is limited understanding of the role that antiretroviral therapy (ART) programs play in the delivery of services for these conditions. The aim of this study is to assess the relationship between ART use and utilization of health care services for diabetes and hypertension.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28696346</PMID><DateCreated><Year>2017</Year><Month>07</Month><Day>11</Day></DateCreated><DateCompleted><Year>2017</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2017</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1944-7884</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>Aug</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of acquired immune deficiency syndromes (1999)</Title><ISOAbbreviation>J. Acquir. Immune Defic. Syndr.</ISOAbbreviation></Journal><ArticleTitle>The ART Advantage: Health Care Utilization for Diabetes and Hypertension in Rural South Africa.</ArticleTitle><Pagination><MedlinePgn>561-567</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/QAI.0000000000001445</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The prevalence of diabetes and hypertension has increased in HIV-positive populations, but there is limited understanding of the role that antiretroviral therapy (ART) programs play in the delivery of services for these conditions. The aim of this study is to assess the relationship between ART use and utilization of health care services for diabetes and hypertension.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa is a cohort of 5059 adults. The baseline study collects biomarker-based data on HIV, ART, diabetes, and hypertension and self-reported data on health care utilization. We calculated differences in care utilization for diabetes and hypertension by HIV and ART status and used multivariable logistic regressions to estimate the relationship between ART use and utilization of services for these conditions, controlling for age, sex, body mass index, education, and household wealth quintile.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Mean age, body mass index, hypertension, and diabetes prevalence were lower in the HIV-positive population (all P < 0.001). Multivariable logistic regression showed that ART use was significantly associated with greater odds of blood pressure measurement [adjusted odds ratio (aOR) 1.27, 95% confidence interval (CI): 1.04 to 1.55] and blood sugar measurement (aOR 1.26, 95% CI: 1.05 to 1.51), counseling regarding exercise (aOR 1.57, 95% CI: 1.11 to 2.22), awareness of hypertension diagnosis (aOR 1.52, 95% CI: 1.12 to 2.05), and treatment for hypertension (aOR 1.63, 95% CI: 1.21 to 2.19).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">HIV-positive patients who use ART are more likely to have received health care services for diabetes and hypertension. This apparent ART advantage suggests that ART programs may be a vehicle for strengthening health systems for chronic care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Manne-Goehler</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>*Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA;†Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA;‡Harvard Center for Population and Development Studies, Harvard University, Cambridge, MA;§Medical Research Council/Wits Rural Public Health and Health Transitions Research Unit, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa;‖Africa Health Research Institute (AHRI), KwaZulu-Natal, South Africa;¶Research Department of Infection and Population Health, University College London, London, United Kingdom;#INDEPTH Network, Accra, Ghana;**Institute of Public Health, University of Heidelberg, Heidelberg, Germany;††Department of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and‡‡Center for Health Decision Science, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montana</LastName><ForeName>Livia</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Gómez-Olivé</LastName><ForeName>Francesc Xavier</ForeName><Initials>FX</Initials></Author><Author ValidYN="Y"><LastName>Rohr</LastName><ForeName>Julia</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Harling</LastName><ForeName>Guy</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Wagner</LastName><ForeName>Ryan G</ForeName><Initials>RG</Initials></Author><Author ValidYN="Y"><LastName>Wade</LastName><ForeName>Alisha</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Kabudula</LastName><ForeName>Chodziwadziwa W</ForeName><Initials>CW</Initials></Author><Author ValidYN="Y"><LastName>Geldsetzer</LastName><ForeName>Pascal</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Tollman</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Berkman</LastName><ForeName>Lisa F</ForeName><Initials>LF</Initials></Author><Author ValidYN="Y"><LastName>Bärnighausen</LastName><ForeName>Till W</ForeName><Initials>TW</Initials></Author><Author ValidYN="Y"><LastName>Gaziano</LastName><ForeName>Thomas A</ForeName><Initials>TA</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>P01 AG041710</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG024409</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Acquir Immune Defic Syndr</MedlineTA><NlmUniqueID>100892005</NlmUniqueID><ISSNLinking>1525-4135</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019380">Anti-HIV Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CitationSubset>X</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Health Aff (Millwood). 2012 Jul;31(7):1459-69</RefSource><PMID Version="1">22778335</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Obesity (Silver Spring). 2017 Jan;25(1):200-206</RefSource><PMID Version="1">27925407</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):e9-e17</RefSource><PMID Version="1">27926667</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2015 Aug 27;373(9):795-807</RefSource><PMID Version="1">26192873</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Diabetes Endocrinol. 2016 Jul;4(7):549-50</RefSource><PMID Version="1">27290621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2008 Sep 13;372(9642):893-901</RefSource><PMID Version="1">18790312</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Health Policy Plan. 2008 Mar;23(2):95-100</RefSource><PMID Version="1">18156161</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Epidemiol. 2014 Feb;43(1):116-28</RefSource><PMID Version="1">24505082</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1:S40-53</RefSource><PMID Version="1">25117960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Health Care Poor Underserved. 2014 Nov;25(4):1723-9</RefSource><PMID Version="1">25418238</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2016 Feb 20;387(10020):811-6</RefSource><PMID Version="1">26299185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hypertens. 2017 Jul;35(7):1345-1352</RefSource><PMID Version="1">28267038</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Global Health. 2008 Sep 16;4:8</RefSource><PMID Version="1">18796148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hum Hypertens. 2008 Mar;22(3):236-9</RefSource><PMID Version="1">18046436</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Diabetes Endocrinol. 2016 Jan;4(1):72-84</RefSource><PMID Version="1">26548379</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 22;339(6122):961-5</RefSource><PMID Version="1">23430655</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Public Health. 2015 Feb 12;15:135</RefSource><PMID Version="1">25885455</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Heart. 2008 Nov;94(11):1376-82</RefSource><PMID Version="1">18519551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Glob Health Action. 2013 Jan 24;6:19305</RefSource><PMID Version="1">23364087</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2012 Jul 31;26 Suppl 1:S19-30</RefSource><PMID Version="1">22781175</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Glob Health Action. 2014 Aug 01;7:24771</RefSource><PMID Version="1">25087686</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Infect Dis. 2015 Oct 14;15:421</RefSource><PMID Version="1">26466584</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Public Health. 2005 Jan;95(1):18-22</RefSource><PMID Version="1">15623853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Rapid Commun Mass Spectrom. 2005;19(21):2995-3001</RefSource><PMID Version="1">16193530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Aug 23;11(8):e0158264</RefSource><PMID Version="1">27552195</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Diabetes Endocrinol. 2015 Sep;3(9):675-7</RefSource><PMID Version="1">26201978</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Public Health. 2017 Feb 17;17 (1):206</RefSource><PMID Version="1">28212629</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Epidemiol. 2012 Aug;41(4):988-1001</RefSource><PMID Version="1">22933647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2016 Nov 13;30(17 ):2685-2695</RefSource><PMID Version="1">27782965</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019380" MajorTopicYN="N">Anti-HIV Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015397" MajorTopicYN="N">Program Evaluation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019035" MajorTopicYN="N">Rural Health Services</DescriptorName><QualifierName UI="Q000656" MajorTopicYN="Y">utilization</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012424" MajorTopicYN="N">Rural Population</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013019" MajorTopicYN="N">South Africa</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28696346</ArticleId><ArticleId IdType="doi">10.1097/QAI.0000000000001445</ArticleId><ArticleId IdType="pii">00126334-201708150-00010</ArticleId><ArticleId IdType="pmc">PMC5516957</ArticleId><ArticleId IdType="mid">NIHMS868921</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000772 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000772 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:28696346
|texte= The ART Advantage: Health Care Utilization for Diabetes and Hypertension in Rural South Africa.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:28696346" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |